Murray Stahl’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$139K Sell
12,584
-604
-5% -$3.69K ﹤0.01% 307
2026
Q1
$101K Sell
13,188
-604
-4% -$4.62K ﹤0.01% 327
2025
Q4
$134K Sell
13,792
-604
-4% -$5.13K ﹤0.01% 304
2025
Q3
$60.3K Buy
14,396
+604
+4% +$3.86K ﹤0.01% 330
2025
Q2
$128K Sell
13,792
-604
-4% -$5.27K ﹤0.01% 329
2025
Q1
$140K Hold
14,396
﹤0.01% 319
2024
Q4
$174K Buy
14,396
+604
+4% +$7.34K ﹤0.01% 319
2024
Q3
$151K Sell
13,792
-604
-4% -$6.13K ﹤0.01% 315
2024
Q2
$130K Hold
14,396
﹤0.01% 302
2024
Q1
$118K Hold
14,396
﹤0.01% 304
2023
Q4
$121K Sell
14,396
-604
-4% -$7K ﹤0.01% 300
2023
Q3
$257K Hold
15,000
0.01% 260
2023
Q2
$348K Hold
15,000
0.01% 252
2023
Q1
$265K Buy
+15,000
New +$357K 0.01% 273

Other funds holding REPL

Murray Stahl's REPL Position: Q2 2026 in Review

Murray Stahl reduced its Replimune Group (REPL) stake by 4.6% in Q2 2026, selling an estimated $3.69K and leaving 12,584 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Murray Stahl first reported a position in REPL in Q1 2023 and has held it in 14 quarters since. The position peaked at $348K in Q2 2023. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Murray Stahl held 12,584 shares of Replimune Group worth $139K as of Q2 2026.
  • Murray Stahl sold 604 Replimune Group shares in Q2 2026, an estimated $3.69K.
  • Replimune Group made up ﹤0.01% of Murray Stahl's portfolio in Q2 2026, its #307 holding.
  • Murray Stahl first reported a position in Replimune Group in Q1 2023 and has held it in 14 quarters since.
  • Murray Stahl's Replimune Group position peaked at $348K in Q2 2023.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.